The South Africa HIV therapeutics market is expected to reach $xx Mn by 2030, up from $89.44 Mn in 2022, with a CAGR of xx% from 2022 to 2030. Local Players such as Cipla Medpro, Adcock Ingram, and Aspen Pharmacare dominate the HIV therapeutics market in South Africa. The government policies, funding, and initiatives by international organizations to manage highly prevalent HIV infections in the country propel market growth. The HIV therapeutics market in South Africa is divided into four segments: type, product, geography, end user, and distribution channel.
South Africa is a country on the African continent's southernmost tip. It also includes the Prince Edward Islands, a small sub-Atlantic archipelago. The HIV therapeutics market in South Africa is expected to reach $xx Mn by 2030, up from $89.44 Mn in 2022, at a CAGR of xx % from 2022 to 2030.
South Africa has the fourth-highest HIV prevalence rate in the world, at 19.10 %. Given the country's large population, this percentage equates to 7.8 Mn HIV-positive people, more than any other country and roughly one-fifth of all HIV cases worldwide. According to the most recent WHO data, HIV/AIDS deaths in South Africa reached 71,996 in 2020, accounting for 15.84 % of total deaths.
South Africa ranks ninth in the world with an age-adjusted death rate of 121.35 per 100,000 population. The AIDS Foundation South Africa is a healthcare organization that works to improve the lives of people living with HIV. In 2020, South Africa spent 8.6 % of its GDP on healthcare.
Market Growth Drivers
The country has the largest ART program in the world, with 68 percent of HIV patients receiving ART by 2021 and 93 % of those patients achieving viral load suppression. HIV/AIDS was also to blame for South Africa's average life expectancy falling to less than 43 years in 2008; it has since risen to 65 years as of 2022. HIV/AIDS remains a serious public health threat, despite the fact that awareness campaigns and the increased availability of anti-retroviral drugs are reducing the number of new cases, allowing infected people to live longer, healthier lives, and reducing mother-child transmissions. HIV transmission from mother to child during birth has decreased from 3.5 % in 2010 to less than 1% in 2021. These factors may entice new entrants into the HIV therapeutics market in South Africa.
Market Restraint
South Africa continues to face skills shortages in several critical industries, including health care and technology. These factors may deter new entrants into the HIV therapeutics market in South Africa.
Key Players
March 2022: The injection, developed by ViiV Healthcare and approved by the US Food and Drug Administration, provides two months of HIV protection and contains the active ingredient cabotegravir. The World Health Organization (WHO) hosted the ground-breaking announcement, which is hoped will boost HIV prevention globally. As an alternative to daily medication, the first injection to provide long-term HIV protection is being rolled out in South Africa and Brazil.
The South African government has established the South African Health Products Regulatory Authority (SAHPRA) to oversee the registration, licensing, and regulation of all health products in the country, including HIV therapeutics. SAHPRA is in charge of assessing the safety, efficacy, and quality of all medicines and health products before they can be used in South Africa. Furthermore, the South African government has undertaken a number of initiatives to increase access to HIV therapeutics. The National Strategic Plan for HIV, Tuberculosis, and Sexually Transmitted Infections 2017-2022 is one such initiative.
The National Department of Health manages the reimbursement of HIV therapeutics in the public health system, allocating funding to provinces for the provision of ART. Provincial health departments are in charge of managing the distribution of ART to clinics and hospitals, where it is given to people living with HIV for free. Medical schemes, which are private health insurance plans, typically manage reimbursement for HIV therapeutics in the private health sector. The Council for Medical Schemes regulates medical schemes, overseeing their operations and ensuring compliance with industry regulations.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Types (Revenue, USD Billion):
By Distribution Channel (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?